American Capital Management Inc buys $20,327,317 stake in MEDNAX Inc (MD)

MEDNAX Inc (MD) : American Capital Management Inc scooped up 255 additional shares in MEDNAX Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 302,220 shares of MEDNAX Inc which is valued at $20,327,317.MEDNAX Inc makes up approximately 1.62% of American Capital Management Inc’s portfolio.

Other Hedge Funds, Including , Mutual Of America Capital Management boosted its stake in MD in the latest quarter, The investment management firm added 4,026 additional shares and now holds a total of 81,338 shares of MEDNAX Inc which is valued at $5,470,794. MEDNAX Inc makes up approx 0.11% of Mutual Of America Capital Management’s portfolio.Palisade Capital Managementnj boosted its stake in MD in the latest quarter, The investment management firm added 5,878 additional shares and now holds a total of 579,367 shares of MEDNAX Inc which is valued at $38,968,224. MEDNAX Inc makes up approx 1.65% of Palisade Capital Managementnj’s portfolio.Gemmer Asset Management boosted its stake in MD in the latest quarter, The investment management firm added 29 additional shares and now holds a total of 215 shares of MEDNAX Inc which is valued at $16,321. MEDNAX Inc makes up approx 0.01% of Gemmer Asset Management’s portfolio.Eagle Asset Management Inc reduced its stake in MD by selling 34,927 shares or 4.51% in the most recent quarter. The Hedge Fund company now holds 740,014 shares of MD which is valued at $55,589,852. MEDNAX Inc makes up approx 0.37% of Eagle Asset Management Inc’s portfolio.

MEDNAX Inc closed down -0.43 points or -0.65% at $65.98 with 4,52,906 shares getting traded on Monday. Post opening the session at $66.42, the shares hit an intraday low of $65.76 and an intraday high of $68.3384 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, MEDNAX Inc reported $1.03 EPS for the quarter, missing the analyst consensus estimate by $ -0.04 based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus of $1.07. The company had revenue of $771.80 million for the quarter, compared to analysts expectations of $774.46 million. The company’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 EPS.

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.

Leave a Reply

MEDNAX Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on MEDNAX Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.